|
Real-time
Oslo Bors
10:45:00 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 0.7000 NOK | +40.56% |
|
-.--% | -49.28% |
| 09-03 | EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Market Cap | 44.28M 4.64M 4.18M 3.86M 3.49M 6.61M 435M 6.77M 46.29M 18.45M 233M 17.41M 17.04M 741M | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 20.37M 2.13M 1.92M 1.78M 1.61M 3.04M 200M 3.11M 21.29M 8.49M 107M 8.01M 7.84M 341M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
28.08% | Yield 2024 * |
-
| Yield 2025 | - |
Oslo BorsNOK
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| EXTX | Real-time | |
Deutsche Boerse AG
| 56F | Delayed |
| 1 day | +40.56% | ||
| 6 months | -45.74% | ||
| Current year | -49.28% |
| Current year | 0.43 |  | 2.7 |
| 1 year | 0.43 | | 2.7 |
| 3 years | 0.43 | | 12.5 |
| 5 years | 0.43 | | 21 |
| 10 years | 0.43 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Svein Kvåle
COO | Chief Operating Officer | - | 2011-12-31 |
Per Walday
CEO | Chief Executive Officer | 66 | 2022-06-05 |
John Edminson
DFI | Director of Finance/CFO | - | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 2018-06-21 | |
Anders Wold
CHM | Chairman | - | 2022-06-07 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/4/23 | Buy | Chairman | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Founder | 2,500 | 0.0083% | ||
| 1/4/23 | Buy | Chief Financial Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +40.56% | -.--% | -51.05% | -94.35% | 4.7M | |
| -1.06% | -0.07% | +60.76% | +68.61% | 67.53B | |
| +1.42% | +8.85% | +14.11% | +92.96% | 60.74B | |
| +0.21% | -0.98% | +20.05% | +98.39% | 55.66B | |
| -0.95% | +11.17% | +22.21% | +110.93% | 47.97B | |
| -0.23% | +4.07% | +25.63% | +40.08% | 45.24B | |
| -6.40% | -9.51% | +181.99% | +816.79% | 39.08B | |
| +1.97% | +3.50% | +25.78% | +50.98% | 35.34B | |
| -1.49% | -3.25% | +78.94% | +55.76% | 33.45B | |
| +1.05% | +9.77% | -37.66% | +408.42% | 26.49B | |
| Average | +4.22% | +1.90% | +34.08% | +164.86% | 41B | |
| Weighted average by Cap. | +0.12% | +1.64% | +43.66% | +168.40% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0.01 0 0.01 0.58 0.01 0.06 0.02 0.31 0.02 0.02 0.99 |
| Net income | -52.33M -5.48M -4.94M -4.56M -4.13M -7.81M -514M -8M -54.7M -21.8M -275M -20.57M -20.13M -876M | -86.97M -9.11M -8.21M -7.58M -6.86M -12.97M -854M -13.29M -90.9M -36.23M -458M -34.19M -33.46M -1.46B |
| Net Debt | -98.89M -10.36M -9.34M -8.62M -7.8M -14.75M -971M -15.11M -103M -41.2M -520M -38.87M -38.05M -1.66B | -23.91M -2.5M -2.26M -2.09M -1.89M -3.57M -235M -3.65M -24.99M -9.96M -126M -9.4M -9.2M -400M |
Employees
11
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
